Inhibiting SARS‐CoV‐2 infection with lysosomal alkalizers

Understanding the SARS‐CoV‐2 virus’ routes of infection, virus–host–protein interactions, and mechanisms of virus‐induced cytopathic effects will greatly aid in the discovery and design of new therapeutics to treat COVID‐19. Chloroquine and hydroxychloroquine, extensively explored as clinical agents...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:FASEB J
Hoofdauteurs: Gorshkov, Kirill, Chen, Catherine, Bostwick, Robert, Rasmussen, Lynn, Tran, Bruce, Cheng, Yu‐Shan, Xu, Miao, Pradhan, Manisha, Henderson, Mark, Zhu, Wei, Oh, Eunkeu, Susumu, Kimihiro, Wolak, Mason, Shamim, Khalida, Huang, Wenwei, Hu, Xin, Shen, Min, Klumpp‐Thomas, Carleen, Itkin, Zina, Shinn, Paul, de la Torre, Juan Carlos, Simeonov, Anton, Michael, Samuel, Hall, Matthew, Lo, Donald, Zheng, Wei
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Federation of American Societies for Experimental Biology 2021
Onderwerpen:
Pharmacology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239884/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fasebj.2021.35.S1.02122
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items